Please also join us on the following dates for additional COVID-19 Townhall updates!
Military OneSource will host DHA experts, allowing them the opportunity to address various topics related to COVID-19, such as:
- Available vaccines and their distribution, safety, and efficacy
- Scheduling appointments within the Military Health System
- Guidance on continued protective measures to slow the spread of the virus
- Personal/real positive outcomes from vaccines
Join us here on the following dates as well:
- May 12, 2021
- May 25, 2021
- June 8, 2021
- June 22, 2021
Get the latest facts about the virus and DHA's response to it. We look forward to seeing you here!
You also may be interested in...
Policy
Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.
Policy
Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.
Policy
This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.
Policy
This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.
Policy
Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.
Policy
Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy
Policy
Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.
Policy
This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.
Policy
This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.
Policy
This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).
Policy
This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.
Policy
Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic
Policy
The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.
Policy
This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.
Policy
This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).
Showing results 1 - 15
Page 1 of 1